Regional
Academy of Medicine of Cincinnati
Drugs and doses39
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 650–1000 mg | PO | not captured | standing | pages 130, 237, 238 |
| Fever | adult | 650–1000 mg | PO | not captured | standing | pages 130, 237 |
| Fever | peds | 120 mg | PO | not captured | standing | pages 130, 237 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | pages 130, 237, 238 |
| Fever | peds | 160 mg | PO | not captured | standing | page 130 |
| Fever | peds | 240 mg | PO | not captured | standing | pages 130, 237 |
| Fever | peds | 320 mg | PO | not captured | standing | page 130 |
| Fever | peds | 40 mg | PO | not captured | standing | pages 130, 237 |
| Fever | peds | 400 mg | PO | not captured | standing | pages 130, 237 |
| Fever | peds | 480 mg | PO | not captured | standing | pages 130, 237 |
| Fever | peds | 80 mg | PO | not captured | standing | pages 130, 237 |
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | pages 142, 143, 166, 237, 238 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 142, 143, 166, 237, 238 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12 mg | IV | not captured | standing | pages 81, 234 |
| Other | adult | 6 mg | IV | not captured | standing | pages 81, 234 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 155, 236 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 237 |
| SVT | adult | 6 mg | IV/IO | not captured | standing | pages 81, 155 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 81, 155 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | pages 105, 163 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | pages 105, 163 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 92, 159 |
| Other | peds | 4 puff | MDI | not captured | standing | page 159 |
| Other | peds | 5 mg | NEB | not captured | standing | page 159 |
| Other | peds | 8 puff | MDI | not captured | standing | page 159 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 80, 234 |
| Wide-complex tachycardia | adult | 300 mg | IV/IO | not captured | standing | pages 75, 152 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 75, 152 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 75, 152 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 75, 152 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 87, 234 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 77, 154, 234 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 77, 154 |
| Bradycardia | peds | 0.04 mg/kg | ET | not captured | standing | page 154 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 237 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 127 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mL | IV/IO | not captured | standing | page 182 |
| Other | adult | 20 mg/kg | IV | not captured | standing | page 124 |
| Other | adult | 20 mg/kg (max 1 g) | IV | not captured | standing | pages 207, 208 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | pages 207, 208 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | pages 207, 208 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 182 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 3 g | IV | not captured | standing | pages 207, 208 |
| Hyperkalemia | adult | 3 g | IV | not captured | standing | pages 207, 208 |
| Hyperkalemia | peds | 2 g | IV | not captured | standing | pages 207, 208 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 234 |
| Other | adult | 2 g | IV | not captured | standing | pages 207, 208 |
| Other | adult | 2 g | IV | not captured | standing | pages 207, 208, 234 |
| Other | adult | 3 g | IV | not captured | standing | pages 207, 208 |
| Other | adult | 3 g | IV | not captured | standing | pages 207, 208, 234 |
| Other | adult | 30 mL | IV/IO | not captured | standing | page 182 |
D–F Dextrose, Diphenhydramine, Epinephrine, Fentanyl4
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | pages 96, 161, 236 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 96, 161, 237 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | pages 96, 161, 236 |
| Other | peds | 10 g | IV/IO | not captured | standing | page 237 |
| Other | peds | 12.5 g | IV/IO | not captured | standing | page 237 |
| Other | peds | 15 g | IV/IO | not captured | standing | page 237 |
| Other | peds | 20 g | IV/IO | not captured | standing | page 237 |
| Other | peds | 25 g | IV/IO | not captured | standing | page 237 |
| Other | peds | 5 g | IV/IO | not captured | standing | page 237 |
| Other | peds | 7.5 g | IV/IO | not captured | standing | page 237 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | IV/IM/PO | not captured | standing | pages 105, 163 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM/PO | not captured | standing | pages 105, 163 |
| Other | adult | 25–50 mg | IV/IM/PO | not captured | standing | pages 105, 163, 234, 236 |
| Other | peds | 1 mg/kg (max 50 mg) | IV/IM/PO | not captured | standing | pages 105, 163, 234, 236 |
| Other | peds | 10 mg | IV/IM | not captured | standing | page 237 |
| Other | peds | 15 mg | IV/IM | not captured | standing | page 237 |
| Other | peds | 20 mg | IV/IM | not captured | standing | page 237 |
| Other | peds | 25 mg | IV/IM | not captured | standing | page 237 |
| Other | peds | 30 mg | IV/IM | not captured | standing | page 237 |
| Other | peds | 40 mg | IV/IM | not captured | standing | page 237 |
| Other | peds | 50 mg | IV/IM | not captured | standing | page 237 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mL | IM | not captured | standing | pages 105, 163 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 105, 163 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 154 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 75, 76, 152, 153 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 75, 76, 152, 153 |
| Hypotension / shock | adult | 0.5–2 mL | IV | not captured | standing | page 54 |
| Hypotension / shock | adult | 5–20 mcg | IV/IO | not captured | standing | pages 54, 84, 125 |
| Other | peds | 0.01 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 152 |
| Other | peds | 0.1 mg | IM | not captured | standing | page 162 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 25–100 mcg | IV/IO | not captured | standing | pages 88, 234 |
| Other | adult | 25–100 mcg | IV/IO | not captured | standing | pages 88, 234 |
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM/IN/SQ | not captured | standing | pages 143, 166, 235 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN/SQ | not captured | standing | pages 143, 166, 235 |
| Severe pain | adult | 25–100 mcg | IV/IO/IM/IN/SQ | not captured | standing | pages 143, 235 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM/SQ | not captured | standing | pages 166, 236, 237 |
| Severe pain | peds | 2 mcg/kg | IN | not captured | standing | pages 166, 236, 237 |
| Post-intubation sedation | adult | 1 mcg/kg | IV/IO | not captured | standing | page 210 |
G–L Glucagon, Hydrocortisone, Hydroxocobalamin, Hypertonic Saline, Ipratropium, Ketamine, Lidocaine7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 96, 161 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | pages 96, 161 |
| Other | adult | 1 mg | IV/IM | not captured | standing | page 105 |
| Other | adult | 1 mg | IM | not captured | standing | pages 96, 161, 234, 236 |
| Other | peds | 0.5 mg | IM | not captured | standing | page 237 |
| Other | peds | 1 mg | IM | not captured | standing | pages 96, 161, 234, 236 |
| Other | peds | 1 mg | IM | not captured | standing | page 237 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IM | not captured | standing | page 123 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 109, 112 |
| Cyanide poisoning | peds | 70 mg/kg (max 5 g) | IV/IO | not captured | standing | pages 109, 112 |
| Other | adult | 5 g | IV/IO | not captured | standing | page 109 |
| Other | peds | 70 mg/kg | IV/IO | not captured | standing | page 109 |
Hypertonic Saline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mL | IV/IO | not captured | standing | pages 137, 235 |
| Other | peds | 100 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 12 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 120 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 160 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 20 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 200 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 4 mL/kg | IV/IO | not captured | standing | pages 137, 168, 237 |
| Other | peds | 40 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 60 mL | IV/IO | not captured | standing | page 237 |
| Other | peds | 80 mL | IV/IO | not captured | standing | page 237 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 92, 159 |
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 92, 234 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 159 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IM | not captured | standing | pages 101, 102 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | pages 143, 166 |
| Mild to moderate pain | adult | 0.5–1 mg/kg | IN | not captured | standing | pages 143, 166 |
| Mild to moderate pain | adult | 0.5–1 mg/kg | IM/SQ | not captured | standing | page 143 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 143, 166 |
| Mild to moderate pain | peds | 0.6 mg/kg | IN | not captured | standing | pages 143, 166 |
| Severe pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | pages 143, 166, 236, 237 |
| Severe pain | adult | 0.5–1 mg/kg | IM/SQ | not captured | standing | page 143 |
| Severe pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 143, 166, 236, 237 |
| Severe pain | peds | 0.6 mg/kg | IN | not captured | standing | pages 166, 236, 238 |
| Post-intubation sedation | adult | 2 mg/kg | IV/IO | not captured | standing | page 210 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | page 80 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 75, 234 |
| Other | adult | 20–40 mg | IV/IO | not captured | standing | page 201 |
| Other | adult | 20–40 mg | IO | not captured | standing | pages 201, 238 |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 201 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | pages 201, 238 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 152, 236, 238 |
| Wide-complex tachycardia | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 75, 152 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | pages 75, 152 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 75, 152 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 75, 152 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nifedipine, Nitroglycerin, Ondansetron, Oral Glucose, Oxymetazoline10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 92 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 92, 234 |
| Other | adult | 4–6 g | IV | not captured | standing | pages 218, 234 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 79, 80 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 123 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 123 |
| Asthma / bronchospasm | adult | 60 mg | IV/PO | not captured | standing | pages 92, 159 |
| Asthma / bronchospasm | peds | 1 mg/kg | IV/PO | not captured | standing | pages 92, 159 |
| Other | adult | 60 mg | IV/PO | not captured | standing | pages 92, 234 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 159, 236 |
| Other | peds | 30 mg | PO | not captured | standing | pages 159, 236 |
| Other | peds | 60 mg | PO | not captured | standing | pages 159, 236 |
| Respiratory distress | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 238 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg | IM | not captured | standing | pages 101, 174 |
| Agitation | peds | 0.2 mg/kg | IM | not captured | standing | pages 101, 174 |
| Other | adult | 2–5 mg | IM/IN | not captured | standing | page 78 |
| Other | adult | 2–5 mg | IM/IN | not captured | standing | pages 79, 234 |
| Other | adult | 2–5 mg | IM/IN | not captured | standing | pages 82, 234 |
| Other | adult | 5 mg | IM | not captured | standing | page 101 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Other | peds | 5 mg | IV/IO/IM/IN | not captured | standing | pages 164, 236 |
| Post-intubation sedation | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 210 |
| Procedural sedation | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | page 77 |
| Procedural sedation | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 79, 82 |
| Seizure | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 234 |
| Seizure | adult | 2–5 mg | IV/IO | not captured | standing | pages 106, 164 |
| Seizure | adult | 5–10 mg | IM/IN | not captured | standing | pages 106, 164 |
| Seizure | adult | 5–10 mg | IN | not captured | standing | page 106 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 106, 164 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 106, 164 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1–5 mg | IV/IO | not captured | standing | page 88 |
| Mild to moderate pain | adult | 2–10 mg | IV/IO/IM/SQ | not captured | standing | pages 143, 166 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM/SQ | not captured | standing | pages 143, 166 |
| Post-intubation sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 210 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4 mg | IN | not captured | standing | page 110 |
| Opioid overdose | adult | 0.4 mg | IV/IO/IM | not captured | standing | page 110 |
| Opioid overdose | peds | 0.1 mg/kg (max 4 mg) | IV/IO/IM | not captured | standing | page 110 |
| Opioid overdose | peds | 0.4 mg | IN | not captured | standing | page 110 |
| Other | adult | 0.4 mg | IV/IO/IM/IN | not captured | standing | pages 110, 234, 235 |
| Other | adult | 0.4–4 mg | IV/IO/IM/IN | not captured | standing | pages 143, 235 |
| Other | peds | 0.04 mg/kg | IM/IN/SQ | not captured | standing | page 233 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 110, 234, 235 |
| Other | peds | 0.3 mg | not captured | not captured | standing | page 238 |
| Other | peds | 0.5 mg | not captured | not captured | standing | page 238 |
| Other | peds | 1 mg | not captured | not captured | standing | page 238 |
| Other | peds | 1.5 mg | not captured | not captured | standing | page 238 |
Nifedipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | PO | not captured | standing | page 219 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 87, 234 |
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 87, 234 |
| ACS / chest pain | adult | 1 inch | TOP | not captured | standing | pages 88, 234 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 94, 234 |
| CHF / pulmonary edema | adult | 0.8 mg | SL | not captured | standing | pages 94, 234 |
| Other | adult | 0.8 mg | SL | not captured | standing | pages 94, 234 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM | not captured | standing | pages 95, 234, 236 |
| Nausea / vomiting | adult | 4–8 mg | PO | not captured | standing | pages 95, 234, 236 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM/PO | not captured | standing | pages 95, 161, 236, 238 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM/PO | not captured | standing | pages 95, 161, 236, 238 |
| Nausea / vomiting | peds | 0.15 mg/kg (max 4 mg) | IV/IO/IM | not captured | standing | pages 95, 234, 236 |
| Nausea / vomiting | peds | 4 mg | PO | not captured | standing | pages 95, 234, 236 |
| Other | adult | 4 mg | IV/IO/IM/PO | not captured | standing | page 141 |
| Other | adult | 4 mg | IV/IO/IM/PO | not captured | standing | page 88 |
| Other | peds | 1.5 mg | IV | not captured | standing | page 238 |
| Other | peds | 2 mg | IV | not captured | standing | page 238 |
| Other | peds | 3 mg | IV | not captured | standing | page 238 |
| Other | peds | 4 mg | IV | not captured | standing | page 238 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 96, 161 |
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 96, 161 |
| Hypoglycemia | peds | 5–15 g | PO | not captured | standing | pages 96, 161 |
| Hypoglycemia | peds | 5–15 g | PO | not captured | standing | pages 96, 161 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 puff | IN | not captured | standing | pages 147, 235 |
P–R Phenylephrine, Pralidoxime, Prednisolone, Prednisone, Promethazine, Proparacaine6
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 puff | IN | not captured | standing | pages 147, 235 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | pages 223, 224 |
Prednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 60 mg | PO | not captured | standing | pages 92, 159 |
| Asthma / bronchospasm | peds | 30 mg | PO | not captured | standing | pages 92, 159 |
| Other | peds | 30 mg | PO | not captured | standing | pages 236, 238 |
| Other | peds | 60 mg | PO | not captured | standing | pages 236, 238 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 60 mg | PO | not captured | standing | pages 92, 159 |
| Asthma / bronchospasm | peds | 30 mg | PO | not captured | standing | pages 92, 159 |
| Other | peds | 30 mg | PO | not captured | standing | pages 159, 236, 238 |
| Other | peds | 60 mg | PO | not captured | standing | pages 159, 236, 238 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IM | not captured | standing | pages 95, 234 |
| Other | adult | 12.5 mg | IM | not captured | standing | pages 95, 234 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | TOP/OPH | not captured | standing | page 141 |
| Mild to moderate pain | adult | 2 drop | OPH | not captured | standing | page 141 |
S–Z Sodium Bicarbonate, Tetracaine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 124, 237 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 124, 237 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 76, 234 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 111 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 237 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 76, 111, 237 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 76, 111, 237 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | TOP/OPH | not captured | standing | page 141 |
| Mild to moderate pain | adult | 2 drop | OPH | not captured | standing | page 141 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mL | IN | not captured | standing | pages 147, 235 |
| Other | adult | 0.5 mL | IN | not captured | standing | pages 140, 147, 235 |
| Other | adult | 1 g | IV/IO | not captured | standing | pages 144, 145, 182, 235, 238 |
| Other | adult | 1 g | IV | not captured | standing | page 182 |
| Other | peds | 1 g | IV/IO | not captured | standing | pages 144, 235 |
| Other | peds | 1 g | IV | not captured | standing | page 182 |
| Other | peds | 1000 mg | IV/IO | not captured | standing | page 238 |
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | pages 144, 145, 182, 235, 238 |
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | page 182 |
| Other | peds | 225 mg | IV/IO | not captured | standing | page 238 |
| Other | peds | 300 mg | IV/IO | not captured | standing | page 238 |
| Other | peds | 375 mg | IV/IO | not captured | standing | page 238 |
| Other | peds | 450 mg | IV/IO | not captured | standing | page 238 |
Cite this
Academy of Medicine of Cincinnati, United States EMS Protocol Census. 243 dose entries, effective 2026-01-01.
https://protoquiz.com/census/agencies/academy-of-medicine-of-cincinnati/
The census is free and not for sale. Only public agencies are named.